Shinji Ohno
A senior breast cancer specialist who has led Japanese arms of adjuvant and metastatic breast cancer trials for two decades.
Shinji Ohno leads the Breast Oncology Center at the Cancer Institute Hospital of JFCR and has been an investigator on CDK4/6, HER2, and adjuvant endocrine trials with Japanese cohorts.
Pages like this
not linked directly; found by shared links- PersonTakayuki Ueno
Shares Cancer Institute Hospital of JFCR, HR-positive / HER2-negative breast cancer.
- PersonJame Abraham
Shares HER2-positive breast cancer, HR-positive / HER2-negative breast cancer.
- PersonClifford A. Hudis
Shares HER2-positive breast cancer, HR-positive / HER2-negative breast cancer.
- PersonJonas Bergh
Shares HER2-positive breast cancer, HR-positive / HER2-negative breast cancer.
- ProductPegulicianine
Shares HER2-positive breast cancer, HR-positive / HER2-negative breast cancer.
- IdeaPublic country dashboards for the three WHO breast cancer targets
Shares HER2-positive breast cancer, HR-positive / HER2-negative breast cancer.
- PersonThomas Bachelot
Shares HER2-positive breast cancer, HR-positive / HER2-negative breast cancer.
- IdeaOne-stop breast clinics: imaging, biopsy and a preliminary answer in a single visit
Shares HER2-positive breast cancer, HR-positive / HER2-negative breast cancer.